Showing results (691-700 of 746) with videos related to

Sort By:
Pageof 75
Gut|September 6, 2015
The stomach in health and diseaseR H Hunt, M Camilleri, S E Crowe, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2019
Renal phospholipidosis and impaired magnesium handling in high-fat-diet-fed miceSteef Kurstjens, Bart Smeets, Caro Overmars-Bos, et al.
The Biochemical Journal|August 17, 2004
Regulation of GLUT1-mediated glucose uptake by PKClambda-PKCbeta(II) interactions in 3T3-L1 adipocytesRemko R Bosch, Merlijn Bazuine, Paul N Span, et al.
Diabetes, Obesity & Metabolism|July 9, 2019
Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trialCees J Tack, Stephan Jacob, Cyrus Desouza, et al.
Transplantation Proceedings|August 16, 2006
Selection criteria and outcome of patients referred to intestinal transplantation: an European center experienceJ Pirenne, I Hoffman, M Miserez, et al.
Diabetes, Obesity & Metabolism|May 22, 2024
Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetesCecilie H Svensson, Therese W Fabricius, Clementine E M Verhulst, et al.
Bone Marrow Transplantation|September 7, 2010
Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapyG J Tack, M J Wondergem, A Al-Toma, et al.
The Journal of Biological Chemistry|July 15, 2018
Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissueDov B Ballak, Suzhao Li, Giulio Cavalli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2001
Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patientsD J Winston, H M Lazarus, R A Beveridge, et al.
The New England Journal of Medicine|June 12, 2019
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesMansoor Husain, Andreas L Birkenfeld, Morten Donsmark, et al.
Pageof 75